{"title":"科学家转变企业家应对糖尿病：新疗法正在酝酿中","authors":"Arjun Jain","doi":"10.33552/ABEB.2019.02.000530","DOIUrl":null,"url":null,"abstract":"A new organization, ET-traps limited, Cambridge has been doing some groundbreaking research in the field of drug development. They have devised a novel approach to target a particular molecule, which has significantly elevated levels in a host of different diseases. It seems amazing that by controlling the levels of the molecule in question, so many hundreds of millions of lives can be dramatically changed.","PeriodicalId":72276,"journal":{"name":"Archives in biomedical engineering & biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Scientist Turned Entrepreneur to Tackle Diabetes: Novel Therapy in the Making\",\"authors\":\"Arjun Jain\",\"doi\":\"10.33552/ABEB.2019.02.000530\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A new organization, ET-traps limited, Cambridge has been doing some groundbreaking research in the field of drug development. They have devised a novel approach to target a particular molecule, which has significantly elevated levels in a host of different diseases. It seems amazing that by controlling the levels of the molecule in question, so many hundreds of millions of lives can be dramatically changed.\",\"PeriodicalId\":72276,\"journal\":{\"name\":\"Archives in biomedical engineering & biotechnology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives in biomedical engineering & biotechnology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33552/ABEB.2019.02.000530\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives in biomedical engineering & biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33552/ABEB.2019.02.000530","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Scientist Turned Entrepreneur to Tackle Diabetes: Novel Therapy in the Making
A new organization, ET-traps limited, Cambridge has been doing some groundbreaking research in the field of drug development. They have devised a novel approach to target a particular molecule, which has significantly elevated levels in a host of different diseases. It seems amazing that by controlling the levels of the molecule in question, so many hundreds of millions of lives can be dramatically changed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
